Every surgical department runs the same conversation each fall. Someone builds a list of what needs replacing, finance asks what can wait another year, and half the list gets deferred. The next fall, the list comes back longer and the deferrals have compounded.
The list is rarely the problem. The routing is. A replacement cycle can be funded two ways, through the capital budget or through the operating budget, and those two paths differ in approval timeline, total cost, reversibility, and political weather. Send a defensible request down the wrong one and it gets deferred three years running for reasons that have nothing to do with whether the request was any good.
Here’s a side-by-side on both routes, and a way to decide which one a given replacement belongs in before you write the first slide.
Two budgets, two different questions
A capital request answers a comparative question: is this asset worth owning for the next several years, and does it beat everything else competing for the same pool of dollars? That pool is finite and system-wide, so your request is implicitly ranked against a cath lab, a parking deck, and an EHR module.
An operating request answers a much narrower one: does this fit inside a departmental budget that was already approved? Nobody ranks it against the parking deck. If the money is in the line, it moves.
What separates the two is a number most OR directors can’t quote from memory: the capitalization threshold. Most health systems set theirs somewhere between $1,000 and $5,000 per unit, with a minimum useful life of a year or more. Anything above the line gets capitalized and depreciated. Anything below it is expensed in the year you buy it.
That threshold quietly decides a great deal. A single hand instrument at $650 sits below almost every threshold in the country, which means it was never a capital item to begin with. It’s a supply expense, approved at the department level, subject to no committee at all. A $40,000 imaging tower is unambiguously capital and gets the full review. Directors who don’t know where their own line sits routinely walk items into a capital committee that never needed to go there, then wait eight months for permission they already had.
What the capital route actually buys you
The capital path is slower and more bureaucratic, and in exchange it gives you three things the operating path can’t.
- Lower cost per unit. Capital purchases are one-time, negotiated, and usually volume-discounted. Nothing accrues after the invoice.
- A depreciation schedule that protects you later. Once an asset is on the books with a defined useful life, replacing it at the end of that life is a documented plan rather than a fresh argument.
- Ownership of the asset. No end-of-term negotiation, no return condition clauses, no usage caps.
The costs are real too. Capital cycles run annually in most systems, with requests due months before the fiscal year opens, which means a mid-year failure waits for the next cycle or goes to a contingency process that is deliberately unpleasant. And capital dollars are visible. A $200,000 request shows up on a board packet with your name on it.
What the operating route actually buys you
Funding through operations, whether that’s a lease, a rental, a per-case arrangement, or simply buying below-threshold items as supplies, inverts every one of those tradeoffs.
- Speed. Weeks instead of quarters, and often no committee at all.
- Reversibility. If volume projections don’t materialize, a lease ends. A purchased asset just sits there depreciating.
- Predictable monthly cost. Easier to model, easier to defend in a departmental review.
What you pay for that flexibility is meaningful. Financed and per-case arrangements typically carry an effective cost well above the purchase price over a multi-year term, and the gap widens the longer you hold. You also inherit terms: minimum volumes, service bundles you may not need, escalators at renewal, and return-condition language that can produce an unpleasant invoice at the end.
Running the comparison honestly
Most side-by-side analyses I see are rigged, usually unintentionally, by comparing an all-in capital number against a monthly operating number without normalizing the horizon. Do it over the asset’s realistic useful life instead, and include four things people leave out:
- Reprocessing cost per turn for anything reusable, which is labor and tray capacity, not just chemistry.
- Service and repair across the full term, whether bundled or billed.
- Attrition, meaning the units you lose or damage annually, which is a supply-line reality nobody budgets for and everybody experiences.
- Salvage or residual value, which is usually near zero and should be stated as such rather than left blank.
On useful life, don’t invent a number. The American Hospital Association’s Estimated Useful Lives of Depreciable Hospital Assets is what most finance offices depreciate against, and the lives it assigns to durable surgical hardware tend to be longer than what OR directors assume. If your request implies a five-year life on something finance carries at ten, that discrepancy will be the first question you get, and it’s a bad question to be surprised by.
Where each path breaks down
Capital fails on timing. Durable hardware degrades continuously and capital arrives discretely, so departments run degraded inventory for months while a request works through a cycle.
Operating fails on accumulation. Nobody notices a lease. Then five of them stack up, the department’s fixed monthly obligation has grown by six figures, and there’s no single decision anyone can point to as the moment it happened. I’d argue this is the more dangerous failure mode of the two, precisely because it never triggers a review. A bad capital request gets rejected; a bad operating commitment just quietly compounds.
What a finance committee is actually asking
Committees are not evaluating your clinical judgment. They’re testing four things, and the requests that survive answer all four before being asked.
What happens if we say no? “Quality would suffer” is not an answer. Deferred maintenance cost, case delay minutes, added reprocessing turns, or a documented failure rate is an answer.
Why this year specifically? Age alone doesn’t justify replacement. A failure curve does. If repair frequency on a set has tripled in eighteen months, that trend line is your argument.
Is this the last request or the first of many? Committees are wary of a foot in the door. Present the full multi-year cycle even when you’re only asking for year one, because the alternative is being treated as unpredictable.
Does it standardize or fragment? Consolidating onto a common platform changes volume math, service assumptions, and SPD tray design all at once. If the plan is to converge your rooms onto one line of high-quality laparoscopic instruments rather than maintaining four surgeon-specific variants, say it plainly. That’s usually the strongest part of the case and it’s the part directors most often bury.
Pick a default, then document the exception
The practical answer for most departments isn’t choosing one path. It’s setting a default and writing down when you’ll break it.
Start by sorting the list by what each line item actually is, because a good deal of what gets called a replacement cycle was never a capital question. Single-use items don’t touch the capital budget under any threshold. They’re consumables: forecast off projected case volume, expensed in-year, and permanently resident in the supply line. That’s the underrated part of the disposable side of the ledger. There’s no reprocessing labor to absorb, no repair curve to track, no sharpening or recalibration schedule, and nothing quietly degrading in a tray while a capital request works its way through committee. Every unit performs the same on its first and only use. Pricing across our laparoscopic instrument range is per-unit and published, so the annual number is case volume times unit cost, which is a spreadsheet exercise rather than a committee argument.
Capital, then, gets reserved for what it’s genuinely for: the durable hardware everything else plugs into, and the long-lived assets with a real depreciation schedule behind them. Own what you’ll use constantly and can predict; finance what’s uncertain or evolving quickly; and keep consumables where they belong, out of the capital conversation entirely so they aren’t competing against a parking deck for approval.
Break the default when the technology is in motion, when volume is genuinely unproven, or when a service line might not survive three years. Those are the situations flexibility is worth paying for.
Write both rules into the department’s capital plan as a single page. It takes an afternoon, it converts an annual argument into an annual update, and it’s the closest thing to a structural fix available to someone who doesn’t control the budget calendar.
